Olema Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Olema Pharmaceuticals

09/08/2022 23:38

* Olema Pharmaceuticals Inc  OLMA.OQ  reported a quarterly
adjusted loss of 82 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Olema Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 82 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Olema Pharmaceuticals Inc shares had risen by 41.3% this
quarter and lost 38.6% so far this year.
    * The company reported a quarterly loss of $32.86 million.
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 10:38 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.64          -0.82          Missed
 Mar. 31 2022      -0.57          -0.58          Missed
 Dec. 31 2021      -0.49          -0.54          Missed
 Sep. 30 2021      -0.46          -0.45          Beat